LONDON, UK: Arix Bioscience’s portfolio company Depixus has successfully completed its oversubscribed Series A financing which raised €30.6 million (£26.1 million). Depixus is a biotechnology company developing a unique technology for the fast, accurate, and straightforward extraction of multiomic information from DNA, RNA, and proteins. Funds from the financing will enable Depixus to further develop…